Navigation Links
Pitt/Iowa team finds cellular structural molecule can be toxic: Makes pneumonia worse
Date:9/20/2010

PITTSBURGH, Sept. 20 A structural molecule and the cellular pump that regulates its levels influence the severity of pneumonia and could provide new ways of treating the lung infection, which is a leading cause of hospitalization and death, according to scientists at the University of Pittsburgh and the University of Iowa. Their findings are available online in Nature Medicine.

Despite decades of research, there has been little new information on what biological mechanisms make bacterial pneumonia get worse, said senior author Rama K. Mallampalli, M.D., a professor in the Acute Lung Injury Center of Excellence, University of Pittsburgh School of Medicine, and pulmonary division chief at the VA Pittsburgh Healthcare System.

"Our study reveals some of the molecular steps that can lead to lung injury after infection and shows us new avenues for pneumonia therapy that don't have to target bacteria, as antibiotics do," he said.

The researchers found that lung fluid from humans and mice with pneumonia contains abnormally high levels of cardiolipin, a structural molecule that is typically found in the membranes of energy-making mitochondria. A carrier protein called Atp8b1 transports the molecule from the lung fluid into the cell, acting as a pump that regulates cardiolipin levels.

Infection leads to the death of cells, and that releases cellular components, including cardiolipin, into the surrounding fluid, Dr. Mallampalli explained. The carrier protein can become overwhelmed, allowing cardiolipin levels to climb. The excess cardiolipin disrupts the function of surfactant, a lubricant that is necessary for the proper expansion and contraction of the lungs during breathing, which can lead to more tissue damage.

When cardiolipin was administered to mice, their lung function became impaired and their lung tissue became damaged akin to what is seen with pneumonia. Similarly, mice with a mutation in the carrier prote
'/>"/>

Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-578-9193
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Duke team finds compounds that prevent nerve damage
2. Study finds genetic variant plays role in cleft lip
3. In a last stronghold for endangered chimpanzees, survey finds drastic decline
4. Brown scientist finds coastal dead zones may benefit some species
5. Study finds high mortality of endangered loggerhead sea turtles in Baja California
6. Yale journal finds nanomaterials may have large environmental footprint
7. UCSB study finds physical strength, fighting ability revealed in human faces
8. NJIT professor finds engineering technique to identify disease-causing genes
9. Grapes may aid a bunch of heart risk factors, animal study finds
10. NC State finds new nanomaterial could be breakthrough for implantable medical devices
11. Pitt research finds that low concentrations of pesticides can become toxic mixture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
(Date:12/3/2014)...   Marvin Test Solutions , a trusted ... military, aerospace, and manufacturing organizations, today announced the ... TS-900 PXI semiconductor test platform . The TS-960 ... to customers at a fraction of the footprint ... "Our semiconductor customers asked for ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... of stem cells such as regenerating damaged tissues or ... the past decade. While these types of applications are exciting, ... most immediate impact of stem cells on human health will ... new drugs. , The ability to generate stem cells by ...
... preservative, may slow or stop squamous cell head and neck ... What makes this particularly good news is that the Food ... as safe for human consumption decades ago, says Yvonne Kapila, ... Michigan School of Dentistry. This means that ...
... release is available in German . ... is a promising anode material for photoelectro-chemical cells (PEC) because ... to the solar spectrum. Although it has the potential of ... lower than that of other metal oxides. This is due ...
Cached Biology News:The role of stem cells in developing new drugs 2Common food preservative may slow, even stop tumor growth 2The hunt for electron holes 2The hunt for electron holes 3
(Date:12/17/2014)... December 17, 2014 This report ... Quartz Tubing industry. For an overview analysis, the ... application, industry chain structure, industry overview, policy analysis, ... tubing industry has witnessed rapid development with ... of acquisitions. This report mentions quartz tubing upstream ...
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 Audacity, ... activation agency and member of the Huntsworth Health Group, ... to its executive team. In her role, Gonzales will ... , “We are incredibly honored to welcome a talent ... Chief and CEO, Gaëtan Fraikin. “She is a proven ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary commercial focus on ... been granted a Type C meeting with the U.S. ... will be held in February 2015.  During this meeting ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce ... V19 with PVM technology , is now available. ... measurement tool continuously captures high-resolution images under a ... automatically prepares a report pairing the most relevant ... changes. This compelling blend of high resolution images ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2
... 2007 versus $5.2 Million ... for Q3 of 2006, -- Gross profit increases 102% to $2.6 Million for ... Million ... Debt to Equity, BEIJING, Nov. 23 /Xinhua-PRNewswire/ -- China Biopharmaceuticals,Holdings, Inc. (OTC Bulletin Board: ...
... Bristol-,Myers Squibb Company (NYSE: BMY ) ... terminating their license agreement for the development of,vinflunine, ... of,advanced or metastatic bladder cancer and other tumor ... licensed to Bristol-Myers Squibb,in 2004 for specific territories. ...
... November 22 ,Essilor yesterday cancelled 700,000 shares as ... dilutive impact of stock option and performance,share plans., ... of Directors authorized the,granting of 930,740 stock options ... potentially lead to the issuance of up to,1,507,004 ...
Cached Biology Technology:China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 2China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 3China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 4China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 5China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 6China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 7
... Rabbit monoclonal [EP282Y] to Asparagine ... all tested applications). ... corresponding to residues in the ... Entrez GeneID: ...
Fluorescein isothiocyanate (FITC) mouse anti-human IFN-alpha2 25 tests...
Mouse monoclonal [M7-PB-E9] to pan alpha Sodium Potassium ATPase ( Abpromise for all tested applications)....
Anti-Cohesin (Scc1/Rad21) Monoclonal Antibody Research Focus: signal transduction Storage: -20C Shipping Temperature: +4C...
Biology Products: